Latest Blog

Last fall, NGM Bio unveiled data from a small group of patients showing its NASH drug cut liver fat in a phase 2 study. Now, the company is reporting results for all 78 patients in the study, showing the treatment…

Dexcom has received approval in Europe extending the use of its wearable continuous glucose monitor to pregnant women across Type 1, Type 2 and gestational diabetes.

Infectious disease blood tester Karius has raised $165 million led by SoftBank’s Vision Fund 2, the Japanese conglomerate’s upcoming sequel to its technology-focused venture capital megafund.

Grifols has struck a deal to buy assets from bankrupt antibiotic developer Aradigm. The agreement sees Grifols waive a $32 million debt and pay $3 million in cash to take full ownership of three assets.

University of Toronto researchers used a live-cell-based screening system to identify drugs that can enter cells and target EGFR mutations in lung cancer. In so doing, they discovered that Astellas’ Xospata and Novartis’ Rydapt, both approved to treat ...

Kadmon has posted positive and more detailed data out of its so-called ROCKstar pivotal trial of KD025 in chronic graft-versus-host disease.

GlaxoSmithKline has struck a deal to provide its pandemic adjuvant to Clover Biopharmaceuticals for use in a COVID-19 vaccine candidate. Clover is one of a clutch of organizations working to tackle COVID-19 by targeting a protein the novel coronavirus ...

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into pharmacies and retail settings.

The Institute for Clinical and Economic Review, also known as drug-pricing watchdog ICER, has partnered with medical data firm Aetion to help analyze the real-world performance of different treatments as it scrutinizes their broader value.

Last fall, a late-stage brain cancer flop prompted Tocagen to cut 65% of its workforce to stay afloat. Now, out of options, the one-time cancer specialist will become Forte Biosciences’ route to the public markets. The duo announced Wednesday that…